{"id":"W4361959012","doi":"10.1158/1078-0432.c.6532443","title":"Data from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Nivolumab; Medicine; Renal cell carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Oncology; Immunotherapy; Urology; Gastroenterology; Cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002020947,0.001050056,0.002335235,0.0002102272,0.0004324066,0.0009394098,0.0007815552,0.001047027,0.004924459],"category_scores_gemma":[0.00148672,0.0005530922,0.001475576,0.000398258,0.0008989744,0.001080419,0.0002758029,0.002673627,0.0009511807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008461581,"about_ca_system_score_gemma":0.001321925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008460899,"about_ca_topic_score_gemma":0.002441255,"domain_scores_codex":[0.9992836,0.0004257309,0.00005413527,0.00009241208,0.00007138805,0.00007289012],"domain_scores_gemma":[0.9987057,0.000339715,0.0002851004,0.0001295065,0.00008354817,0.0004562839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.943997,0.01009629,0.00203959,0.0006092931,0.001748858,0.00008000724,0.00006925482,0.0008446206,0.007781704,0.0001272117,0.00262291,0.02998328],"study_design_scores_gemma":[0.8598197,0.1293947,0.005763435,0.00004091824,0.0009064635,0.0001099432,0.00003155079,0.0005351594,0.001167456,0.0001624563,0.002044556,0.0000236734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9822182,0.004941899,0.0008781364,0.0008869627,0.0004095136,0.003785425,0.002851075,0.00009296013,0.003936011],"genre_scores_gemma":[0.9865389,0.002307627,0.001397283,0.001567931,0.0002912839,0.002682199,0.003052349,0.0000347561,0.002127412],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.004924459,"threshold_uncertainty_score":0.01647389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06666745171825833,"score_gpt":0.3217843807728177,"score_spread":0.2551169290545594,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}